Join Eupraxia Pharma ($EPRX) for a virtual KOL event on May 9 at 9am ET featuring Dr. Evan Dellon, who will join company management to discuss clinical data from the Phase 1b/2a RESOLVE Study evaluating EP-104GI for eosinophilic esophagitis. Register: bit.ly/3EUKiUm

Join Xeris Pharmaceuticals $XERS for an in-person and virtual analyst and investor day on June 3 at 10am ET with key opinion leaders, to discuss unmet medical needs and the outlook for Recorlev® and XP-8121. In-person RSVP: bit.ly/4d8xbvi; Virtual RSVP: bit.ly/3Z8MfmZ

Join @BioVie Inc. $BIVI for a virtual KOL event on May 28 at 12pm ET featuring Drs. Suzanne de la Monte and Mark Stacy, who will join company management to discuss the unmet need and current treatment landscape for Parkinson's disease. Register: bit.ly/3GQDEiN

Join Cidara Therapeutics $CDTX for a virtual R&D Day on May 22 at 10am ET featuring Drs. Fred Hayden and Rick Bright, who will join company management to discuss CD388 as a potential universal, once-per-flu season preventative of influenza. Register: bit.ly/43eUQFT

Don’t miss the Xeris Pharmaceuticals $XERS in-person and virtual analyst and investor day on June 3 at 10am ET, including a discussion with Dr. Eliza Geer on Cushing’s syndrome and updates on Recorlev®. In-person RSVP: bit.ly/4d8xbvi; Virtual RSVP: bit.ly/3Z8MfmZ

Join @Pharvaris $PHVS for a virtual R&D call on June 4 at 8AM ET to discuss the potential of their investigational drug #deucrictibant in addressing the unmet needs of people living with #BradykininMediatedAngioedema. A live Q&A will follow. Register now: bit.ly/4krOTwl

Join Sagimet Biosciences $SGMT for a virtual KOL event on May 29 at 1pm ET with Dr. Loomba, who will discuss the potential for developing a combination of denifanstat and resmetirom to treat advanced metabolic dysfunction-associated steatohepatitis (MASH). Register: bit.ly/45pMGgD

Join ImmixBio (NASDAQ:IMMX) $IMMX for a virtual KOL event on June 3 at 3pm ET with Drs. Landau, Raza and Zonder to discuss interim NEXICART-2 Phase 1/2 trial results of NXC-201 for relapsed/refractory AL Amyloidosis following its 2025 ASCO presentation. Register: bit.ly/4dwxOPw

Join DiaMedica Therapeutics $DMAC for a virtual KOL event on May 28 at 8am ET featuring Professors Sibai, Tong and Walker, who will discuss the unmet need and treatment landscape for preeclampsia, and review the Phase 2 trial design and key endpoints. Register: bit.ly/43MtXuq

Join Galectin Thera: GALT for a virtual KOL event on June 16 at 12pm ET with Dr. Chalasani and Dr. Alkhouri, who will join company management to discuss the unmet need and current treatment landscape for MASH cirrhosis and portal hypertension. Register: bit.ly/3ZZulUb

Join Sagimet Biosciences $SGMT for a virtual KOL event on June 16 at 2pm ET with Dr. Bhatia to review positive efficacy and tolerability results from Ascletis’ Phase 3 trial evaluating denifanstat for moderate to severe acne vulgaris in China. Register: bit.ly/3HUpXiY

Join PDS Biotechnology $PDSB for a virtual KOL event on June 17 at 12pm ET featuring Dr. Harrington and Dr. Price, who will discuss the unmet need and current treatment landscape for recurrent/metastatic HPV16-positive HNSCC. Register: bit.ly/4dXovIV

Join I-Mab Biopharma $IMAB for a KOL webinar on July 8 at 2pm ET featuring Dr. Klempner, who will discuss new givastomig data. Givastomig, a potential best-in-class, Claudin 18.2 x 4-1BB bispecific antibody, is being evaluated in gastric cancers. Register: bit.ly/4kLWKWi

Join Heidelberg Pharma for an R&D webinar on June 17 at 11am ET featuring Dr. Strassz, CMO Heidelberg Pharma, and Professors Kaufman and Raab, who will discuss recent data of lead candidate, HDP-101, in relapsed or refractory Multiple Myeloma. Register: bit.ly/3TrTkMa

Join Elicio Therapeutics $ELTX for a virtual KOL event on June 25 at 2pm ET featuring Dr. Irvine and Dr. O'Reilly, who will discuss the unmet need and current treatment landscape for mKRAS PDAC, one of the most lethal and underserved solid tumors. Register: bit.ly/4n4wtnu

Join Lipocine $LPCN for a virtual R&D investor event featuring Dr. Kristina M. Deligiannidis, who will join company management to discuss the current treatment landscape and unmet need in postpartum depression (PPD). Register: bit.ly/448JJit

Join Everest Medicines for a virtual KOL event with Dr. Richard Lafayette and company management to discuss the pMN treatment landscape in the US and China and data from the EVER001 trial. Register for English: bit.ly/4njkUcg Register for Chinese: bit.ly/3I1tL2b

Join Oncolytics Biotech $ONCY for a KOL webinar on July 22 at 1:00 PM ET to discuss pelareorep in mPDAC and other gastrointestinal cancers featuring Dr. Dirk Arnold, Dr. Alexander Eggermont, Dr. Sanjay Goel, and Dr. Devalingam Mahalingam. Register: lifescievents.com/event/cu8w3mvm…

Join Hyperion $HYPD for a corporate update event on July 29 at 2pm ET with CIO Hyunsu Jung and CEO Michael Rowe, to discuss the Company's transformation into the first U.S. public firm focused on building a strategic treasury around HYPE. Register: lifescievents.com/event/gqlg98ac…

Join iMDx Inc. $IMDX for a virtual KOL event on August 15 at 4pm ET with Dr. Anthony Langone, NPI for iMDx’s kidney transplant trial, to discuss the role of dd-cfDNA in transplant care, patient management, and the benefits of in-house testing. Register: lifescievents.com/event/pwfy3c9a…